North Star Investment Management Corp. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 92 filers reported holding TG THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 6.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
North Star Investment Management Corp. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36,784
-66.3%
4,4000.0%0.00%
-66.7%
Q2 2023$109,296
+65.2%
4,4000.0%0.01%
+80.0%
Q1 2023$66,176
+27.1%
4,4000.0%0.01%0.0%
Q4 2022$52,052
+100.2%
4,4000.0%0.01%
+66.7%
Q3 2022$26,000
+36.8%
4,4000.0%0.00%
+50.0%
Q2 2022$19,000
-93.2%
4,400
-85.0%
0.00%
-90.9%
Q1 2022$280,000
+330.8%
29,400
+764.7%
0.02%
+340.0%
Q4 2021$65,000
-42.5%
3,4000.0%0.01%
-44.4%
Q3 2021$113,000
-45.4%
3,400
-83.8%
0.01%
-71.0%
Q1 2020$207,000
-11.2%
21,0000.0%0.03%
+29.2%
Q4 2019$233,000
+97.5%
21,0000.0%0.02%
+84.6%
Q3 2019$118,000
-35.2%
21,0000.0%0.01%
-38.1%
Q2 2019$182,000
+7.7%
21,0000.0%0.02%
+5.0%
Q1 2019$169,000
+96.5%
21,0000.0%0.02%
+81.8%
Q4 2018$86,000
-27.1%
21,0000.0%0.01%
-15.4%
Q3 2018$118,000
-57.2%
21,0000.0%0.01%
-59.4%
Q2 2018$276,000
-7.4%
21,0000.0%0.03%
-11.1%
Q1 2018$298,000
+73.3%
21,0000.0%0.04%
+71.4%
Q4 2017$172,000
-30.9%
21,0000.0%0.02%
-34.4%
Q3 2017$249,000
+18.0%
21,0000.0%0.03%
+14.3%
Q2 2017$211,000
-13.9%
21,0000.0%0.03%
-17.6%
Q1 2017$245,000
+432.6%
21,000
+110.0%
0.03%
+385.7%
Q4 2016$46,00010,0000.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders